ESC Premium Access

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: a 1-year analysis of the REDUCE trial

Congress Presentation

About the speaker

Doctor Monica Verdoia

ASL Biella Hospital of the Sick University of Eastern Piedmont, Biella (Italy)
1 presentation
0 follower

9 more presentations in this session

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Speaker: Doctor H. Wada (Kyoto, JP)

Thumbnail

Association of atherogenic dyslipidemia with cardiovascular outcomes in patients with pre-diabetes and coronary artery disease

Speaker: Doctor Y. Gao (Beijing, CN)

Thumbnail

Extremely elevated lipoprotein (a) as an independent risk factor for coronary heart disease in large patient cohort

Speaker: Mr M. Poudel (Bielefeld, DE)

Thumbnail

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study

Speaker: Miss M. Wada (Kyoto, JP)

Thumbnail

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

Speaker: Professor O. Mayer (Pilsen, CZ)

Thumbnail

Access the full session

Poster Session 6 - Long term prognosis in coronary artery disease

Speakers: Doctor M. Verdoia, Doctor H. Wada, Doctor Y. Gao, Mr M. Poudel, Miss M. Wada...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb